Suresh K. Durgam Intra Cellular Therapies, Inc. (ITCI) insider trading activity

Suresh K. Durgam is EVP, Chief Medical Officer of Intra-Cellular Therapies, Inc.. Currently has a direct ownership of 0 shares of ITCI, which is worth approximately $0. The most recent transaction as insider was on Feb 21, 2023, when has been sold 8,354 shares (Common Stock) at a price of $48.0 per share, resulting in proceeds of $400,992. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Suresh K. Durgam Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 21 2023	SELL Open market or private sale	$400,992 $48.0 p/Share	8,354 Reduced 26.56%	23,104 Common Stock
Feb 18 2023	BUY Exercise of conversion of derivative security	-	8,354 Added 20.98%	31,458 Common Stock
Mar 04 2022	SELL Open market or private sale	$214,307 $55.52 p/Share	3,860 Reduced 14.32%	23,104 Common Stock
Mar 02 2022	SELL Open market or private sale	$238,005 $56.98 p/Share	4,177 Reduced 13.41%	26,964 Common Stock
Feb 24 2022	SELL Open market or private sale	$211,080 $52.17 p/Share	4,046 Reduced 11.5%	31,141 Common Stock
Feb 23 2022	BUY Exercise of conversion of derivative security	-	7,906 Added 18.35%	35,187 Common Stock
Feb 22 2022	SELL Open market or private sale	$230,403 $55.16 p/Share	4,177 Reduced 13.28%	27,281 Common Stock
Feb 18 2022	BUY Exercise of conversion of derivative security	-	8,354 Added 20.98%	31,458 Common Stock
Jan 18 2022	SELL Open market or private sale	$261,553 $42.03 p/Share	6,223 Reduced 21.22%	23,104 Common Stock
Jan 10 2022	SELL Open market or private sale	$279,266 $40.65 p/Share	6,870 Reduced 18.98%	29,327 Common Stock
Jan 08 2022	BUY Exercise of conversion of derivative security	-	13,093 Added 26.56%	36,197 Common Stock
Feb 19 2021	SELL Open market or private sale	$106,817 $39.07 p/Share	2,734 Reduced 10.58%	23,104 Common Stock
Feb 18 2021	BUY Exercise of conversion of derivative security	-	8,354 Added 24.43%	25,838 Common Stock
Jan 11 2021	SELL Open market or private sale	$139,176 $31.87 p/Share	4,367 Reduced 19.99%	17,484 Common Stock
Jan 08 2021	BUY Exercise of conversion of derivative security	-	13,092 Added 37.47%	21,851 Common Stock

SKD

Suresh K. Durgam

EVP, Chief Medical Officer

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ITCI shares.

Notify only if

Value

Insider Trading

Get notified when an Intra Cellular Therapies, Inc. insider buys or sells ITCI shares.

Notify only if

Operation

Value

Type

News

Receive news related to Intra-Cellular Therapies, Inc.

Track Activities on ITCI

Account